FDA Inspection
VitalantVitalant – FDA Inspection, Aug 19, 2014
Record Details
This FDA Inspection record concerns Vitalant, with an inspection on August 19, 2014, issued by the Center for Biologics Evaluation and Research, covering biologics.
- Company
- Vitalant
- Inspection Date
- August 19, 2014
- Product Type
- Biologics
View Company Profile
ID · 48e8778c-92cb-455b-830e-e65b43bf214d
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 893648
- FDA center
- Biologics
- Project area
- Blood and Blood Products
FDA Citations
1- 21 CFR 606.100(b)(9)Written methods for investigating adverse reactions
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Vitalant
5| Date | Classification | Office | Project area |
|---|---|---|---|
| July 25, 2025 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| December 13, 2022 | NAI | Center for Biologics Evaluation and Research | Vaccines and Allergenic Products |
| August 15, 2019 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| May 12, 2017 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| September 21, 2010 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
Other documents for Vitalant
- FDA Inspection 1278306 - 2025-07-25
- FDA Inspection 1194142 - 2022-12-13
- FDA Inspection 1101686 - 2019-08-15
- FDA Inspection 1017593 - 2017-05-12
- FDA Inspection 681411 - 2010-09-21
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.